Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ACTRN12626001211358) titled 'Feasibility and acceptability of an intranasal blank sol-gel administration in healthy adults and individuals diagnosed with schizophrenia' on Sept. 30.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety
Primary Sponsor: Metro South Hospital land Health Services
Condition:
schizophrenia
schizophrenia
Mental Health - Schizophrenia
Intervention:
This study aims to assess the tolerability of a novel sol-gel nose to brain delivery system in healthy adults and individuals diagnosed with...